Accordingly, it has been found that mutant p53 induces miR-128-3p and its host gene ARPP-21, leading to p53 mutation-mediated chemoresistance in NSCLC and an oncogenic function for miR-128-3p shows in lung cancer (71). The gene discussed is ARPP21; the disease is lung carcinoma.